Kallikrein Inhibitor Peptide
Kallikrein Inhibitor Peptide
Product description
Kallikreins (tissue and plasma kallikreins) are serine proteases that liberate kinins (bradykinin and kallidin) from the kininogens, which are plasma proteins that are converted into vasoactive peptides. The Kallikrein Inhibitor Peptide corresponds to aa386-391 of bovine kininogen-1 that encompasses the aa388-389 kallikrein proteolytic site. The synthetic kallikrein inhibitor can attenuate breast cancer cell invasion, therefore it is investigated for its role in invasion and metastasis of cancer cells.
| Appearance | N/A |
|---|---|
| Molecular weight | N/A |
| Purity | >95% |
| Solubility | Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile. |
| Sequence | Ac-Pro-Phe-Arg-Ser-Val-Gln-NH2 or Ac-PFRSVQ-NH2 |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
MSDS of Kallikrein Inhibitor Peptide
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


